Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP3A4 | P08684 | 5/20 | 1.00 |
| ▸ | CYP2C8 | P10632 | 5/20 | 1.00 |
| ▸ | CYP2C9 | P11712 | 5/20 | 1.00 |
| ▸ | CYP2B6 | P20813 | 5/20 | 1.00 |
| ▸ | CYP2C19 | P33261 | 5/20 | 1.00 |
| ▸ | CYP1A2 | P05177 | 4/20 | 1.00 |
| ▸ | ALOX5 | P09917 | 3/20 | 0.73 |
| ▸ | HTR1A | P08908 | 5/20 | 0.72 |
| ▸ | CYP2D6 | P10635 | 3/20 | 0.72 |
| ▸ | CYP2A6 | P11509 | 3/20 | 0.72 |
| ▸ | LTA4H | P09960 | 3/20 | 0.72 |
| ▸ | CYP2E1 | P05181 | 2/20 | 0.72 |
| ▸ | TRPV1 | Q8NER1 | 3/20 | 0.72 |
| ▸ | OR51E2 | Q9H255 | 1/20 | 0.70 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4877010 | 1.00 | CYP3A4 (1.00) | CYP3A4CYP2C8CYP2C9CYP2B6CYP2C19 | |
| SCHEMBL29711594 | 1.00 | CYP3A4 (1.00) | CYP3A4CYP2C8CYP2C9CYP2B6CYP2C19 | |
| SCHEMBL30417499 | 1.00 | CYP3A4 (1.00) | CYP3A4CYP2C8CYP2C9CYP2B6CYP2C19 | |
| SCHEMBL4881362 | 1.00 | CYP3A4 (1.00) | CYP3A4CYP2C8CYP2C9CYP2B6CYP2C19 | |
| SCHEMBL29371372 | 1.00 | CYP3A4 (1.00) | CYP3A4CYP2C8CYP2C9CYP2B6CYP2C19 | |
| SCHEMBL29801887 | 1.00 | CYP3A4 (1.00) | CYP3A4CYP2C8CYP2C9CYP2B6CYP2C19 | |
| SCHEMBL29805047 | 1.00 | CYP3A4 (1.00) | CYP3A4CYP2C8CYP2C9CYP2B6CYP2C19 | |
| SCHEMBL4883880 | 1.00 | CYP3A4 (1.00) | CYP3A4CYP2C8CYP2C9CYP2B6CYP2C19 | |
| SCHEMBL4885822 | 1.00 | CYP3A4 (1.00) | CYP3A4CYP2C8CYP2C9CYP2B6CYP2C19 | |
| SCHEMBL17546694 | 0.99 | CYP3A4 (0.97) | CYP3A4CYP2C8CYP2C9CYP2B6CYP2C19 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 498 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4683527-A1 | VAPORIZABLE ALKALOID COMPOSITIONS AND METHODS OF USE THEREOF | Ready Mix Naturals, LLC (US) | 2026-01-28 | — | — | EP | claimed |
| US-12497381-B2 | Vaporizable alkaloid compositions and methods of use thereof | Ready Mix Naturals, LLC (US) | 2025-12-16 | — | — | US | claimed |
| US-12478091-B2 | Vaporizable alkaloid compositions and methods of use thereof | Ready Mix Naturals, LLC (US) | 2025-11-25 | — | — | US | claimed |
| WO-2025202300-A1 | COMPLEX COACERVATES FOR NUTRACEUTICALS | NEKTIUM PHARMA S.L. (ES) | 2025-10-02 | — | — | WO | claimed |
| EP-4623703-A1 | COMPLEX COACERVATES FOR NUTRACEUTICALS | Nektium Pharma S.L. (ES) | 2025-10-01 | — | — | EP | claimed |
| US-20250289796-A1 | COMPOSITIONS AND METHODS OF USE THEREOF | Ready Mix Naturals, LLC (US) | 2025-09-18 | — | — | US | claimed |
| EP-4599698-A1 | PRODUCTS COMPRISING SENSORY AGENTS | Nicoventures Trading Limited (GB) | 2025-08-13 | — | — | EP | claimed |
| US-12358888-B2 | Vaporizable alkaloid compositions and methods of use thereof | Ready Mix Naturals, LLC (US) | 2025-07-15 | — | — | US | claimed |
| US-12358889-B2 | Vaporizable alkaloid compositions and methods of use thereof | Ready Mix Naturals, LLC (US) | 2025-07-15 | — | — | US | claimed |
| EP-3515215-B1 | AGENTS FOR MODULATING THE SENSORY IMPACT OF TOBACCO OR HERBAL SMOKE | SENTIENS LLC (US) | 2025-06-11 | — | — | EP | claimed |
| WO-2013185843-A1 | COSMETIC COMPOSITIONS COMPRISING HYALURONAN BIOSYNTHESIS PROMOTING AGENTS | SYMRISE AG (DE) | 2013-12-19 | — | — | WO | claimed |
| US-8592621-B2 | Precursor compounds of sweet taste receptor antagonists for the prevention or treatment of disease | SYMRISE AG (DE) | 2013-11-26 | — | — | US | claimed |
| WO-2013090410-A1 | DEVICE AND METHOD FOR SIMULATING CHEMOSENSATION OF SMOKING | SENTIENS, LLC (US) | 2013-06-20 | — | — | WO | claimed |
| US-20130152956-A1 | DEVICE AND METHOD FOR SIMULATING CHEMOSENSATION OF SMOKING | SENTIENS, LLC (US) | 2013-06-20 | — | — | US | claimed |
| US-20110045069-A1 | PRECURSOR COMPOUNDS OF SWEET TASTE RECEPTOR ANTAGONISTS FOR THE PREVENTION OR TREATMENT OF DISEASE | SYMRISE GMBH CO. KG (DE) | 2011-02-24 | — | — | US | claimed |
| WO-2010062581-A2 | A BOTANICAL COMPOSITION FOR ENHANCED SKIN REPAIR AND USES THEREOF | THE REGENTS OF THE UNIVERSITY OF MICHIGAN (US) | 2010-06-03 | — | — | WO | claimed |
| US-20100105644-A1 | BOTANICAL COMPOSITION FOR ENHANCED SKIN REPAIR AND USES THEREOF | THE REGENTS OF THE UNIVERSITY OF MICHIGAN (US) | 2010-04-29 | — | — | US | claimed |
| US-20040156799-A1 | Cancer treatment method and compositions | REGENTS OF THE UNIVERSITY OF MINNESOTA | 2004-08-12 | — | — | US | claimed |
| EP-1392266-A2 | CANCER TREATMENT METHOD AND COMPOSITIONS COMPRISING COMPOUNDS OF THE GINGER FAMILY | REGENTS OF THE UNIVERSITY OF MINNESOTA (US) | 2004-03-03 | — | — | EP | claimed |
| WO-2002098399-A2 | CANCER TREATMENT METHOD AND COMPOSITIONS COMPRISING COMPOUNDS OF THE GINGER FAMILY | REGENTS OF THE UNIVERSITY OF MINNESOTA (US) | 2002-12-12 | — | — | WO | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (7 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040156799-A1 | Cancer treatment method and compositions | H4C1; H4C2; H4C3; H4C4; H4C5; H4C6; H4C8; H4C9; H4C11; H4C12; H4C13; H4C14; H4C15; H4C16, KRAS, TP53 | CYP3A4 2758/4885CYP2C8 3585/4885CYP2C9 3381/4885 |
| US-20100105644-A1 | BOTANICAL COMPOSITION FOR ENHANCED SKIN REPAIR AND USES THEREOF | CUTA, COL14A1, BACH1 | CYP3A4 2202/4885CYP2C8 958/4885CYP2C9 1615/4885 |
| US-20250289796-A1 | COMPOSITIONS AND METHODS OF USE THEREOF | OR10J3, TRPA1, TAS2R3 | CYP3A4 1035/4885CYP2C8 627/4885CYP2C9 794/4885 |
| US-12358888-B2 | Vaporizable alkaloid compositions and methods of use thereof | SRM, SCLY, SMOX | CYP3A4 823/4885CYP2C8 493/4885CYP2C9 279/4885 |
| US-12358889-B2 | Vaporizable alkaloid compositions and methods of use thereof | SRM, SCLY, SMOX | CYP3A4 823/4885CYP2C8 493/4885CYP2C9 279/4885 |
| US-12497381-B2 | Vaporizable alkaloid compositions and methods of use thereof | CHRM5, NNMT, CHRM1 | CYP3A4 301/4885CYP2C8 583/4885CYP2C9 164/4885 |
| US-20110045069-A1 | PRECURSOR COMPOUNDS OF SWEET TASTE RECEPTOR ANTAGONISTS FOR THE PREVENTION OR TREATMENT OF DISEASE | TAS1R2, TAS2R5, TAS2R1 | CYP3A4 4088/4885CYP2C8 4141/4885CYP2C9 4382/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.